Howard S. Hochster, MD, FACP
In these videos, Howard S. Hochster, MD, FACP, associate director for clinical research and director of gastrointestinal oncology at Rutgers Cancer Institute, discusses:
- the benefits of targeting genomic alterations using gene analysis;
- the importance of identifying mutations — such as RAS, KRAS and BRAF — and how these and other factors such as location of tumors, can affect survival outcomes;
- how advances in treatments have improved survival outcomes for patients with metastatic colorectal cancer;
- how circulating tumor DNA could change the treatment and diagnosis of colon cancer and other unmet needs of patients;
- what's in the pipeline and how the development of drugs that can address KRAS drivers could transform the treatment landscape; and
- disparity issues in the diagnosis and treatment of colorectal cancer.